TGF-β and Smad3 Signaling Link Inflammation to Chronic Fibrogenesis1
暂无分享,去创建一个
Jack Gauldie | K. Flanders | M. Kolb | J. Gauldie | K. Ask | P. Bonniaud | P. Margetts | Martin Kolb | Philippe Bonniaud | Kjetil Ask | Kathy Flanders | Peter J. Margetts
[1] R. Strawderman,et al. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival. , 2001, The American journal of medicine.
[2] M. Sporn,et al. Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes , 1989, The Journal of cell biology.
[3] C. Daniels,et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. , 2004, The Journal of clinical investigation.
[4] H. Lodish,et al. Role of Transforming Growth Factor in Human Disease , 2000 .
[5] A. Roberts,et al. Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis1 , 2004, The Journal of Immunology.
[6] James B. Mitchell,et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. , 2002, The American journal of pathology.
[7] J. Munger. The integrin αvβ6 binds and activates latent TGFβ1 : A mechanism for regulating pulmonary inflammation and fibrosis , 1999 .
[8] F. Graham,et al. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. , 1998, The American journal of pathology.
[9] A. Mauviel,et al. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles. , 2004, The international journal of biochemistry & cell biology.
[10] J. Gauldie. Inflammatory Mechanisms Are Not a Minor Component of the Pathogenesis of Idiopathic Pulmonary Fibrosis , 2002 .
[11] J. Enghild,et al. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. , 2003, Free radical biology & medicine.
[12] M. Schmidt,et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. , 2001, American journal of respiratory and critical care medicine.
[13] L. Wakefield,et al. IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent , 2004, The Journal of Immunology.
[14] C. Heldin,et al. Smad regulation in TGF-beta signal transduction. , 2001, Journal of cell science.
[15] K. Csaky,et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.
[16] O. Eickelberg. Endless healing: TGF‐β, SMADs, and fibrosis , 2001 .
[17] A. Pardo,et al. Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.
[18] J. Gauldie. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.
[19] R. Strieter. Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. , 2002, American journal of respiratory and critical care medicine.
[20] A. Roberts. The ever-increasing complexity of TGF-β signaling , 2002 .
[21] M. Kolb,et al. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. , 2005, American journal of respiratory and critical care medicine.
[22] D. Anthony,et al. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. , 2001, The Journal of clinical investigation.
[23] Serhiy Souchelnytskyi,et al. Smad regulation in TGF-β signal transduction , 2022 .
[24] P. Sime,et al. A new direction in the pathogenesis of idiopathic pulmonary fibrosis? , 2001, Respiratory research.
[25] G. Izbicki,et al. Time course of bleomycin‐induced lung fibrosis , 2002, International journal of experimental pathology.
[26] H. Lodish,et al. Role of transforming growth factor beta in human disease. , 2000, The New England journal of medicine.
[27] S. Sone,et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. , 2005, American journal of respiratory and critical care medicine.
[28] R. Strieter. Inflammatory Mechanisms Are Not a Minor Component of the Pathogenesis of Idiopathic Pulmonary Fibrosis , 2002 .
[29] R. Homer,et al. Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.
[30] Rakesh K. Kumar. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2002, Respiratory Research.
[31] D. Warburton,et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[32] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.
[33] David Shimabukuro,et al. Injury and repair in lung and airways. , 2003, Critical care medicine.
[34] D. Friend,et al. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] F. Graham,et al. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Alving,et al. Update in Hematology , 2001, Annals of Internal Medicine.